r. Ayelet Erez earned a BSc and MD, both cum laude, at the Technion-Israel Institute of Technology. She specialized in pediatrics at Safra Children's Hospital in the Sheba Medical Center and earned a PhD in cancer genetics from Tel Aviv University. She completed a Clinical Genetics residency program together with a postdoctoral fellowship at Baylor College of Medicine in Houston, Texas. She then worked as an assistant professor of Molecular and Human Genetics at Baylor College of Medicine and as a medical geneticist at Texas Children's Hospital. She joined the Weizmann Institute's Department of Biological Regulation in 2012 where she is currently an Associate Professor and the Dean of the MD PhD program. Her research focuses on understanding the host-tumor interactions through the prism of metabolism for translational relevance. In parallel, she established a pediatric cancer genetic clinic at Schneider Hospital to nurture the bridge from scientific discoveries to new treatments, where she volunteers weekly. Dr. Erez's professional and academic honors include receiving twice the ERC consolidator grant, the Rappaport Prize, and the Mark Foundation Endeavor.
Tuesday, 17 June 2025
Time |
Session |
|
15:20
16:55
|
-
Modeling cachexia in mice: from intestinal cancer models to distinct host trajectories
-
Proffered Paper: Oncolytic virus (CVA21) in combination with pembrolizumab increases tumour cell immunogenicity and remodels the tumour microenvironment in advanced NSCLC: a phase I/II trial
EACR25-1995
EACR25-1995
-
Insights into cancer cachexia from the TRACERx lung cancer study
-
Proffered Paper: Translational control shapes Treg cell fate in the tumor microenvironment
EACR25-2124
EACR25-2124
-
Exploring the tumor MACROenvironment for improving cancer diagnosis and therapy (REMOTE PRESENTATION)
Auditorium VIII
|